Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Exercise Test × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Lung Neoplasms 7 Colorectal Neoplasms 6 Prostatic Neoplasms 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 2 Obesity 2 Neoplasms 2 Multiple Myeloma 2 Motor Activity 2 Lymphoma, Non-Hodgkin 2 Hematopoietic and Lymphoid System Neoplasm 2 Gastrointestinal Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Trastuzumab Cardiotoxicity 1 Sleep Wake Disorders 1 Sedentary Behavior 1 Sarcopenia 1 Radiation Pneumonitis 1 Radiation Fibrosis Syndrome 1 Polycystic Ovary Syndrome 1 Pelvic Neoplasms 1 Pathologically Proven Gastrointestinal Malignancy 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myocardial Fibrosis 1

Interventions

pembrolizumab 256 Nivolumab 233 Ipilimumab 212 aldesleukin 120 Cyclophosphamide 119 Interleukin-2 89 trametinib 75 dabrafenib 67 Dacarbazine 62 fludarabine 61 Vemurafenib 61 Temozolomide 59 fludarabine phosphate 54 Biopsy 43 Radiosurgery 42 sargramostim 39 Bevacizumab 39 incomplete Freund's adjuvant 35 binimetinib 34 Paclitaxel 33 Magnetic Resonance Spectroscopy 32 atezolizumab 31 Specimen Handling 31 Radiotherapy 31 Cisplatin 31 Introns 30 Blood Specimen Collection 30 cobimetinib 29 encorafenib 28 Carboplatin 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008977 2025-06-04

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡